[go: up one dir, main page]

KR870004028A - 디하이드로리세르그산 에스테르 및 그의 제조방법 - Google Patents

디하이드로리세르그산 에스테르 및 그의 제조방법

Info

Publication number
KR870004028A
KR870004028A KR1019860008205A KR860008205A KR870004028A KR 870004028 A KR870004028 A KR 870004028A KR 1019860008205 A KR1019860008205 A KR 1019860008205A KR 860008205 A KR860008205 A KR 860008205A KR 870004028 A KR870004028 A KR 870004028A
Authority
KR
South Korea
Prior art keywords
dihydroliseric
acid ester
preparing same
preparing
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019860008205A
Other languages
English (en)
Other versions
KR880001009B1 (ko
Inventor
리 가브레흐트 윌리암
푸르넬 마조니 지포드
존 팔리 캐롤
로즈 화이튼 카트린
로이스 코헨 말렌
워드 풀러 레이
Original Assignee
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/782,341 external-priority patent/US4713385A/en
Priority claimed from US06/782,337 external-priority patent/US4683236A/en
Priority claimed from US06/782,338 external-priority patent/US4713384A/en
Priority claimed from US06/782,340 external-priority patent/US4714704A/en
Priority claimed from US06/782,342 external-priority patent/US4772709A/en
Application filed by 일라이 릴리 앤드 캄파니 filed Critical 일라이 릴리 앤드 캄파니
Publication of KR870004028A publication Critical patent/KR870004028A/ko
Application granted granted Critical
Publication of KR880001009B1 publication Critical patent/KR880001009B1/ko
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019860008205A 1985-10-01 1986-09-30 디하이드로리세르그산 에스테르 및 그의 제조방법 Expired KR880001009B1 (ko)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US782342 1985-10-01
US782337 1985-10-01
US782338 1985-10-01
US782341 1985-10-01
US06/782,341 US4713385A (en) 1985-10-01 1985-10-01 Alkoxy and dialkoxyalkyl esters of dihydrolysergic acid and related compounds useful as 5HT receptor antagonists
US782340 1985-10-01
US06/782,337 US4683236A (en) 1985-10-01 1985-10-01 Cycloalkanol esters of dihydrolysergic acid useful as 5Ht2 receptor antagonists
US06/782,338 US4713384A (en) 1985-10-01 1985-10-01 Selective method for blocking 5HT2 receptors
US06/782,340 US4714704A (en) 1985-10-01 1985-10-01 Alkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US06/782,342 US4772709A (en) 1985-10-01 1985-10-01 Process of making ketoalkanol esters of dihydrolysergic acid

Publications (2)

Publication Number Publication Date
KR870004028A true KR870004028A (ko) 1987-05-07
KR880001009B1 KR880001009B1 (ko) 1988-06-13

Family

ID=27542204

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860008205A Expired KR880001009B1 (ko) 1985-10-01 1986-09-30 디하이드로리세르그산 에스테르 및 그의 제조방법

Country Status (17)

Country Link
EP (1) EP0219257B1 (ko)
JP (1) JPH0723376B2 (ko)
KR (1) KR880001009B1 (ko)
AR (1) AR244687A1 (ko)
AU (1) AU594373B2 (ko)
CY (1) CY1784A (ko)
DE (1) DE3689702T2 (ko)
DK (1) DK466886A (ko)
ES (1) ES2002392A6 (ko)
GR (1) GR862466B (ko)
HK (1) HK51894A (ko)
HU (1) HU206711B (ko)
IE (1) IE61976B1 (ko)
IL (1) IL80193A0 (ko)
MY (1) MY102598A (ko)
NZ (1) NZ217724A (ko)
PT (1) PT83450B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734501A (en) * 1985-10-01 1988-03-29 Eli Lilly And Company N-alkylation of dihydrolysergic acid
US4782063A (en) * 1987-05-11 1988-11-01 Eli Lilly And Company Ergoline esters useful as serotonin antagonists
GB8824744D0 (en) * 1988-10-21 1988-11-30 Erba Carlo Spa Antiemesis ergoline derivatives
CA2218143A1 (en) * 1995-04-18 1996-10-24 Eli Lilly And Company Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor
US5880134A (en) * 1996-03-20 1999-03-09 Eli Lilly And Company Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor
EP2846763B1 (de) * 2012-05-08 2017-02-08 Merck Patent GmbH Verwendung von cyclohexanolethern mit antimikrobiellen eigenschaften

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3580916A (en) * 1969-02-20 1971-05-25 Lilly Co Eli Hydroxyesters of hexa- and octahydroindoloquinolines
CH549571A (de) * 1970-09-16 1974-05-31 Lilly Co Eli Verfahren zur herstellung von estern der lysergsaeure bzw. dihydrolysergsaeure und deren verwendung.
US4563461A (en) * 1983-03-10 1986-01-07 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4734501A (en) * 1985-10-01 1988-03-29 Eli Lilly And Company N-alkylation of dihydrolysergic acid
US4713384A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Selective method for blocking 5HT2 receptors

Also Published As

Publication number Publication date
PT83450A (en) 1986-10-01
IE61976B1 (en) 1994-12-14
HUT41780A (en) 1987-05-28
GR862466B (en) 1987-02-02
EP0219257B1 (en) 1994-03-09
AU6321086A (en) 1987-04-02
HU206711B (en) 1992-12-28
IE862588L (en) 1987-04-01
PT83450B (pt) 1989-05-12
ES2002392A6 (es) 1988-08-01
AR244687A1 (es) 1993-11-30
CY1784A (en) 1995-10-20
DE3689702T2 (de) 1994-07-28
KR880001009B1 (ko) 1988-06-13
MY102598A (en) 1992-08-17
DE3689702D1 (de) 1994-04-14
JPH0723376B2 (ja) 1995-03-15
JPS6284084A (ja) 1987-04-17
IL80193A0 (en) 1986-12-31
DK466886A (da) 1987-04-02
DK466886D0 (da) 1986-09-30
EP0219257A2 (en) 1987-04-22
EP0219257A3 (en) 1988-12-28
HK51894A (en) 1994-05-27
AU594373B2 (en) 1990-03-08
NZ217724A (en) 1989-02-24

Similar Documents

Publication Publication Date Title
KR860004830A (ko) 테레프탈산의 제조방법 및 이를 위한 장치
GR861065B (en) 7-amido-3-propenylcephalosporanic acid and esters thereof method for their preparation
KR860005834A (ko) N-보호된-α-L-아스파르틸-L-페닐알라닌 메틸 에스테르의 제조방법
BR1100475A (pt) •steres de alcenamidocefalosporina
DK295386A (da) 3-substitueret propenylaminothiazolyl-cephalosporansyrer og estere deraf
KR860005581A (ko) 연체류 양식 방법과 그 장치
KR860004857A (ko) 치환된 디하이드로퀴놀론 카복실산 및 그의 제조 방법
KR870004028A (ko) 디하이드로리세르그산 에스테르 및 그의 제조방법
PL277488A1 (en) Method of obtaining n-phosphono-methyliminoacetic acid
FI885154A7 (fi) Sialosyyliglyserolipidejä ja menetelmä niiden valmistamiseksi
KR860005779A (ko) 부탄디카복실산 에스테르의 제조방법
FI863471A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
GR861006B (en) Vinylcyclopropancarbon acid ester
KR860004829A (ko) 신나메이트 에스테르의 제조방법
GB8700165D0 (en) Carbamic acid ester derivatives
DK303786A (da) Fremgangsmaade til fremstilling af 3-amino-4-hydroxybenzoesyrer
PL263216A1 (en) Method of obtaining azoniaspironortropanol esters
DK401786D0 (da) Substituerede cyclohexanalkansyrer samt fremgangsmaade til fremstilling deraf
FI862043A7 (fi) Menetelmä 2-tiokromenyylideeniasetetikkaesterien valmistamiseksi.
DK565086D0 (da) Fremgangsmaade til fremstilling af 5-chlor- og 5-brom-2-hydroxynikotinsyrer
IL79464A0 (en) Naphthyridine-carboxylic acid esters
ZA863307B (en) Permethric acid triazolyl-alkyl esters
DK559185A (da) Sulfamoylbenzoesyrederivater samt fremgangsmaade til fremstilling deraf
SE8502932D0 (sv) Novel androstane-17beta-carboxylic acid esters
BG40064A1 (en) Method for obtaining ureido- beta- lactomic acids and their salts

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 19950323

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19960614

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19960614

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000